Zantra Ltd v BASF Plc

Zantra Ltd v BASF Plc

The claimant satisfied all criteria for a Norwich Pharmacal order: there is an arguable case of anti-competitive concerted action by national distributors, the information sought is necessary to bring a claim, and the defendant is mixed up in the alleged wrongdoing. The order is proportionate and justified in the circumstances.

Parties
Claimant: Zantra Limited; Defendant: BASF PLC
Jurisdiction
England and Wales
Judgment Date
24 November 2016
Procedural Posture
Part 8 Proceedings (norwich Pharmacal Application) / Judgment on Application for Norwich Pharmacal Order
Outcome
Norwich Pharmacal order granted
Legal Topics
Norwich Pharmacal Orders, Disclosure of Information, Concerted Practices, Breach of Competition Rules, Chapter 1 Competition Act 1998, Article 101 TFEU

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 3 Authorities cited 6 Party arguments 2 Amounts and remedies 3
Sign in to unlock

Parties

Zantra Limited

Claimant

BASF PLC

Defendant

Procedural Posture

Part 8 Proceedings (norwich Pharmacal Application) / Judgment on Application for Norwich Pharmacal Order

  1. 1 Whether the claimant is entitled to a Norwich Pharmacal order for disclosure of information to identify potential wrongdoers allegedly involved in anti-competitive conduct.
  2. 2 Whether there is a sufficiently arguable case of a breach of competition law by national distributors through concerted action.

Ratio Decidendi

The claimant satisfied all criteria for a Norwich Pharmacal order: there is an arguable case of anti-competitive concerted action by national distributors, the information sought is necessary to bring a claim, and the defendant is mixed up in the alleged wrongdoing. The order is proportionate and justified in the circumstances.

Court Disposition

Norwich Pharmacal order granted

Orders

  • Defendant to disclose all documents recording discussions with national distributors within the relevant timeframe.
  • Defendant to provide a witness statement setting out the content of those discussions.